BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3842648)

  • 21. Pulmonary vascular impedance: resistance versus pulmonary artery diastolic-pulmonary artery occluded pressure gradient.
    Hilgenberg JC
    Anesthesiology; 1983 May; 58(5):484-6. PubMed ID: 6838007
    [No Abstract]   [Full Text] [Related]  

  • 22. Blunting of stress responses in the pulmonary circulation of infants by fentanyl.
    Hickey PR; Hansen DD; Wessel DL; Lang P; Jonas RA; Elixson EM
    Anesth Analg; 1985 Dec; 64(12):1137-42. PubMed ID: 4061893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of chronic application of aminorex-fumarate on the pulmonary circulation of the rat].
    Engelhardt R; Kalbfleisch H
    Arzneimittelforschung; 1973 Aug; 23(8):1057-61. PubMed ID: 4801026
    [No Abstract]   [Full Text] [Related]  

  • 24. A documented episode of pulmonary vasoconstriction in systemic sclerosis.
    Naslund MJ; Pearson TA; Ritter JM
    Johns Hopkins Med J; 1981 Feb; 148(2):78-80. PubMed ID: 7206403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute effects of N-chloropropyl-amphetamine (Ro 4-5282) on the hemodynamics of human macro- and microcirculation].
    Fey M; Gurtner HP
    Arzneimittelforschung; 1972 Dec; 22(12):2090-2. PubMed ID: 4679176
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of glucagon on pulmonary vascular resistance.
    Kirsh MM; Kahn DR; Lucchesi B; Gago O; Dufek JH; Lee RW; Stutz D; Sloan H
    Surgery; 1971 Sep; 70(3):439-42. PubMed ID: 5568529
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disorders of pulmonary and systemic circulation in chronic nonspecific lung diseases. I. Hemodynamics of pulmonary circulation].
    Tendera M; Zołna J; Poloński L; Pluta W; Lekston A
    Pneumonol Pol; 1983 Mar; 51(3):145-55. PubMed ID: 6878062
    [No Abstract]   [Full Text] [Related]  

  • 28. The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.
    Mukerjee D; Yap LB; Ong V; Denton CP; Howells K; Black CM; Coghlan JG
    Ann Rheum Dis; 2004 Dec; 63(12):1627-31. PubMed ID: 15547087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt-sensitivity in borderline hypertension.
    Fujita T; Noda H; Ando K; Sato Y; Ito Y
    Jpn Circ J; 1984 Nov; 48(11):1285-7. PubMed ID: 6389924
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary vascular overreactivity in systemic hypertension. A pathophysiological link between the greater and the lesser circulation.
    Fiorentini C; Barbier P; Galli C; Loaldi A; Tamborini G; Tosi E; Guazzi MD
    Hypertension; 1985; 7(6 Pt 1):995-1002. PubMed ID: 4077227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of catecholamines on the lesser circulation].
    Kuprianov VS
    Kardiologiia; 1973 Nov; 13(11):103-7. PubMed ID: 4783432
    [No Abstract]   [Full Text] [Related]  

  • 32. [State of the indices of external respiration and hemodynamics in the greater and lesser circulations in hypertension].
    Lazidi GKh
    Kardiologiia; 1979 Feb; 19(2):44-8. PubMed ID: 423436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The right ventricle and pulmonary circulation in hypertensive patients].
    Guazzi MD; Riva S; Guazzi M; Dardani M; Berti M; Tosi E; Alimento M
    Recenti Prog Med; 1990 Apr; 81(4):209-14. PubMed ID: 2198638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental analysis of pulmonary circulatory disorders in the acute period of myocardial infarct].
    Khomaziuk AI; Neshcheret AP
    Kardiologiia; 1967 May; 7(5):109-14. PubMed ID: 5608081
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sympathicus excitability and vascular reactivity in normotensive subjects and in patients with essential hypertension].
    Philipp T; Cordes U; Zschiedrich H; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():283-5. PubMed ID: 611964
    [No Abstract]   [Full Text] [Related]  

  • 36. Vascular reactivity in systemic arterial hypertension.
    Mendlowitz M
    Am Heart J; 1973 Feb; 85(2):252-9. PubMed ID: 4569756
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary vasoconstrictor overreactivity in borderline systemic hypertension.
    Moruzzi P; Sganzerla P; Guazzi MD
    Cardiovasc Res; 1989 Aug; 23(8):666-73. PubMed ID: 2598222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of anisodamine and scopolamine on pulmonary circulation in rabbits].
    Fan YL; Yang L; Wang XQ; Sun HL; Sun YW; Hu F; Zhou WQ; Xiao YZ
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):117-21. PubMed ID: 2946145
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pulmonary circulation in juvenile systemic hypertension].
    Widimský J; Jandová R; Ressl J
    Cesk Fysiol; 1981; 30(2):175-9. PubMed ID: 7285193
    [No Abstract]   [Full Text] [Related]  

  • 40. [Potential of proteinase-activated receptors as a novel target for treatment of pulmonary hypertension].
    Hirano K
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):182-6. PubMed ID: 24717606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.